National All Schedules Prescription Electronic Reporting Act Of 2005
I thank my friend for yielding me the time. Mr. Speaker, this is a bill that we have been working hard to get passed for some time now. I would like to begin by really thanking all the people who have helped us get this bill to the floor.…
I thank my friend for yielding me the time.
Mr. Speaker, this is a bill that we have been working hard to get passed for some time now. I would like to begin by really thanking all the people who have helped us get this bill to the floor. The gentleman from Kentucky (Mr. Whitfield) and his staff have just done amazing work. A few years ago, I had a bill like this and the gentleman from Kentucky had a bill like this and it shows that we can work together. We merged our bill and came out with a good product today. I do appreciate the efforts of our Democratic cosponsors, the gentleman from New Jersey (Mr. Pallone) and the gentleman from Ohio (Mr. Strickland). I would like to also thank Chairman Barton and Chairman Deal and Ranking Members Dingell and Brown for recognizing the importance of this issue and helping us move forward.
Mr. Speaker, prescription drug abuse in this country is a serious problem. I know it. I have seen it. It is a subject with which I have some experience. I experienced it in Vietnam treating wounded soldiers. I experienced it in my dental practice. Some say there is no such thing as doctor-shopping. That is pure nonsense. I have seen it many times in my own life. I have experienced it personally after a car wreck. I feel strongly that we do not do a good enough job in this country to alleviate pain, and morally and ethically we should. But if we do not deal with this misuse of prescription drugs, we are going to have less pain relief than more.
I also know that the drugs that relieve the most severe pain can always, almost always, be the most dangerous. They can create a dependency. They can be diverted by the abusers. We have a responsibility to find ways to fight drug abuse without in any way dampening the ability of doctors to treat their patients in severe pain.
In fact, the abuse and diversion of prescription drugs is a growing public health issue for this Nation, and we need to recognize it and understand it.
From major cities to the smallest rural towns, we have had to deal with the consequences of prescription drug abuse. Prescription drugs now rank second only to marijuana in abuse. Think about that. Over 31 million American adults and adolescents have at one time abused pain relievers. Prescription medications are emerging as the drugs of choice for abuse by America's teenagers. According to a national study released earlier this year, approximately one in five teenagers, that is over 4 million of our sons and daughters, have abused prescription painkillers. Surveys also show that they abuse them because they can, because access is just simply too easy. Mr. Speaker, those numbers are appalling. But there are human faces behind each headline and report of abuse. Their families and their communities suffer along with those who become addicted.
Those who help divert drugs allow these medications to get into the hands of our children as well as adults who have no medical needs. Most physicians have recognized the tremendous benefit State programs in place today are already having, and they have lined up behind our legislation because we could cross State lines.
In an effort to address the problem of prescription drug abuse, 21 States have implemented prescription drug monitoring programs. They are in place today. But in our case, if we have one in Georgia, right across the river in South Carolina we cannot deal with it. In a prescription drug monitoring program, pharmacists are required to provide a standard set of information to a State database when dispensing a controlled substance. The administrator of the State database can then alert appropriate authorities if data indicates abuse or diversion.
A doctor or a pharmacist can check that database to see if a patient could be abusing a prescription drug. Think about it. There are other great consequences from that. The confidentiality of, and access to, the information is protected to the best of our ability, and we think it has been done very well. We have worked very hard on that to try to get privacy rights. H.R. 1132 is a bill that would allow the Secretary of Health and Human Services to fund more of these State-monitoring programs. In exchange for Federal funding, the States agree to set up these programs if they do not have them or, if they do have them, improve the ones they already have.
But there must be some basic Federal standards. Border States must also be able to communicate. This closes a serious loophole in States' current efforts to fight drug abuse. If an abuser can simply cross a State line to avoid detection, the monitoring system cannot work; or if an abuser is doctor-shopping, as I have seen happen, it is very hard to catch him. Through this bill we are encouraging all the States to get on board with a system that works while respecting States' rights and people's privacy.
I ask and encourage all of our colleagues to join us in supporting this very important bill.